In 2003, Shinyo et al. [9] showed for the first time that HPA mRNA expression is increased in advanced cervical cancer, and that HPA expression is higher in patients with vessel and lymphatic duct involvement. The gene discussed is HPSE; the disease is cervical carcinoma.